Cytek Biosciences Inc (CTKB) Stock Price, Quote, News & History

CTKBNASDAQ
$4.92
-0.02-0.40%
At close: May 6, 5:00 PM EST
$4.44
-0.50-10.12%
Pre-Market: 4:03 AM EST
Earnings: Q1 2026 Earnings were released on Thu May 7th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 1 day ago
Click to view the webcast
Loading...

Key Statistics

Open
-
Close
$4.92
Volume / Avg.
4.14K / 725.85K
Day Range
- - -
52 Wk Range
2.37 - 6.18
Market Cap
$573.39M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
7.95%
Days to Cover
17.17

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-4.69M
Investing Cash Flow (TTM)
10.12M
Financing Cash Flow (TTM)
-13.43M
Free Cash Flow (TTM)
-8.88M
Capital Expenditure (TTM)
-4.19M
Net Change in Cash (TTM)
-8.00M

Analyst Trends and Forecast

1
Nov 25
1
Jan
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$397.60M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
3.12
PB Ratio (TTM)
1.86
Earnings Yield % (TTM)
-10.57%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.65

Company Debt

Total Debt
$6.82M
LT Debt
$525.00K
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$4.75M
Total Cash
$90.85M
Debt to Equity
0.07
Issuance of Debt (TTM)
-$4.75M
Repayment of Debt (TTM)
-$4.75M

Key Statistics

Open
-
Close
$4.92
Volume / Avg.
4.14K / 725.85K
Day Range
- - -
52 Wk Range
2.37 - 6.18
Market Cap
$573.39M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
7.95%
Days to Cover
17.17

About

Sector
Health Care
Industry
Life Sciences Tools & Services
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish f...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Cytek Biosciences (CTKB) stock?

A

You can purchase shares of Cytek Biosciences (NASDAQ:CTKB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cytek Biosciences (CTKB) competitors?

Q

What is the forecast, or price target, for Cytek Biosciences (CTKB) stock?

A

Cytek Biosciences has a consensus price target of $5.70.

Q

What is the current price for Cytek Biosciences (CTKB)?

A

The stock price for Cytek Biosciences (NASDAQ: CTKB) is $4.44 last updated May 8, 2026 at 4:00 AM EDT.

Q

Does Cytek Biosciences (CTKB) pay a dividend?

A

There are no upcoming dividends for Cytek Biosciences.

Q

When is Cytek Biosciences (NASDAQ:CTKB) reporting earnings?

A

Cytek Biosciences does not have any upcoming earnings scheduled.

Q

Is Cytek Biosciences (CTKB) going to split?

A

There is no upcoming split for Cytek Biosciences.

Q

What sector and industry does Cytek Biosciences (CTKB) operate in?

A

Cytek Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.